T3D Therapeutics, Inc. Awarded SBIR Phase 2 Grant From The National Institute On Aging For Alzheimer’s Disease Drug Testing

Mar 24, 2015 | News | 0 comments

NIA/NIH grant support for Phase 2a clinical testing of a new, potentially disease-modifying
therapy tor Alzheimer’s disease.